These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38658764)

  • 1. PGE
    Morotti M; Grimm AJ; Hope HC; Arnaud M; Desbuisson M; Rayroux N; Barras D; Masid M; Murgues B; Chap BS; Ongaro M; Rota IA; Ronet C; Minasyan A; Chiffelle J; Lacher SB; Bobisse S; Murgues C; Ghisoni E; Ouchen K; Bou Mjahed R; Benedetti F; Abdellaoui N; Turrini R; Gannon PO; Zaman K; Mathevet P; Lelievre L; Crespo I; Conrad M; Verdeil G; Kandalaft LE; Dagher J; Corria-Osorio J; Doucey MA; Ho PC; Harari A; Vannini N; Böttcher JP; Dangaj Laniti D; Coukos G
    Nature; 2024 May; 629(8011):426-434. PubMed ID: 38658764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGE
    Lacher SB; Dörr J; de Almeida GP; Hönninger J; Bayerl F; Hirschberger A; Pedde AM; Meiser P; Ramsauer L; Rudolph TJ; Spranger N; Morotti M; Grimm AJ; Jarosch S; Oner A; Gregor L; Lesch S; Michaelides S; Fertig L; Briukhovetska D; Majed L; Stock S; Busch DH; Buchholz VR; Knolle PA; Zehn D; Dangaj Laniti D; Kobold S; Böttcher JP
    Nature; 2024 May; 629(8011):417-425. PubMed ID: 38658748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E₂ down-regulates the expression of CD25 on bovine T cells, and this effect is mediated through the EP4 receptor.
    Maślanka T; Spodniewska A; Barski D; Jasiecka A; Zuśka-Prot M; Ziółkowski H; Markiewicz W; Jaroszewski JJ
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):192-200. PubMed ID: 25001909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-intrinsic prostaglandin E
    Lee J; Aoki T; Thumkeo D; Siriwach R; Yao C; Narumiya S
    J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
    Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
    Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E
    Goepp M; Crittenden S; Zhou Y; Rossi AG; Narumiya S; Yao C
    Immunology; 2021 Dec; 164(4):777-791. PubMed ID: 34529833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action.
    Take Y; Koizumi S; Nagahisa A
    Front Immunol; 2020; 11():324. PubMed ID: 32210957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer.
    Akbari B; Soltantoyeh T; Shahosseini Z; Jadidi-Niaragh F; Hadjati J; Brown CE; Mirzaei HR
    Front Immunol; 2023; 14():1209572. PubMed ID: 37457723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
    Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
    Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient T-cell priming and activation requires signaling through prostaglandin E2 (EP) receptors.
    Sreeramkumar V; Hons M; Punzón C; Stein JV; Sancho D; Fresno M; Cuesta N
    Immunol Cell Biol; 2016 Jan; 94(1):39-51. PubMed ID: 26051593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.
    Holt DM; Ma X; Kundu N; Collin PD; Fulton AM
    J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling.
    Boniface K; Bak-Jensen KS; Li Y; Blumenschein WM; McGeachy MJ; McClanahan TK; McKenzie BS; Kastelein RA; Cua DJ; de Waal Malefyt R
    J Exp Med; 2009 Mar; 206(3):535-48. PubMed ID: 19273625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1.
    Chang HH; Young SH; Sinnett-Smith J; Chou CE; Moro A; Hertzer KM; Hines OJ; Rozengurt E; Eibl G
    Am J Physiol Cell Physiol; 2015 Nov; 309(10):C639-49. PubMed ID: 26310818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of trophoblast derived prostaglandin E2 receptor 2 (EP2) is reduced in patients with recurrent miscarriage and EP2 regulates cell proliferation and expression of inflammatory cytokines.
    Peng L; Ye Y; Mullikin H; Lin L; Kuhn C; Rahmeh M; Mahner S; Jeschke U; von Schönfeldt V
    J Reprod Immunol; 2020 Nov; 142():103210. PubMed ID: 33011635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2.
    Qian X; Gu L; Ning H; Zhang Y; Hsueh EC; Fu M; Hu X; Wei L; Hoft DF; Liu J
    J Immunol; 2013 Jun; 190(11):5894-902. PubMed ID: 23645882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E
    Mangelsen E; Rothe M; Schulz A; Kourpa A; Panáková D; Kreutz R; Bolbrinker J
    Cells; 2020 May; 9(5):. PubMed ID: 32438662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous prostaglandin E
    Samuchiwal SK; Balestrieri B; Raff H; Boyce JA
    J Biol Chem; 2017 May; 292(20):8195-8206. PubMed ID: 28341741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
    Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGE2-EP4 signaling steers cDC2 maturation toward the induction of suppressive T-cell responses.
    Cuenca-Escalona J; Flórez-Grau G; van den Dries K; Cambi A; de Vries IJM
    Eur J Immunol; 2024 Mar; 54(3):e2350770. PubMed ID: 38088451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.